↓ Skip to main content

American Association for Cancer Research

A combinatorial CRISPR-Cas9 screen identifies ifenprodil as an adjunct to sorafenib for liver cancer treatment

Overview of attention for article published in Cancer Research, December 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
10 news outlets
twitter
10 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
27 Mendeley
Title
A combinatorial CRISPR-Cas9 screen identifies ifenprodil as an adjunct to sorafenib for liver cancer treatment
Published in
Cancer Research, December 2021
DOI 10.1158/0008-5472.can-21-1017
Pubmed ID
Authors

Feng Xu, Man Tong, Cindy S W Tong, Becky K C Chan, Hoi Yee Chu, Tin Lok Wong, John H C Fong, Maggie S H Cheung, Kylie Hin-Man Mak, Lakhansing Pardeshi, Yuanhua Huang, Koon Ho Wong, Gigi C G Choi, Stephanie Ma, Alan S L Wong

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 11%
Student > Ph. D. Student 2 7%
Lecturer 1 4%
Student > Bachelor 1 4%
Professor 1 4%
Other 2 7%
Unknown 17 63%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 19%
Agricultural and Biological Sciences 1 4%
Computer Science 1 4%
Immunology and Microbiology 1 4%
Medicine and Dentistry 1 4%
Other 1 4%
Unknown 17 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 77. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2022.
All research outputs
#539,439
of 24,862,965 outputs
Outputs from Cancer Research
#312
of 18,992 outputs
Outputs of similar age
#13,703
of 514,504 outputs
Outputs of similar age from Cancer Research
#10
of 111 outputs
Altmetric has tracked 24,862,965 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,992 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 514,504 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.